Tag: Editorial Message

Editorial Message and Issue Highlights–Vol. 15, No. 5–6, May-June 2018

Editorial Message and Issue Highlights–Vol. 15, No. 5–6, May-June 2018

| May 1, 2018 | 0 Comments

Dear Colleagues: Welcome to the May–June 2018 issue of Innovations in Clinical Neuroscience (ICNS). We start the issue with a timely review article by Touma and Scarff titled, “Valbenazine and Deutetrabenazine for Tardive Dyskinesia (TD).” Here, the authors discuss the two drugs, which were recently approved by the United States Food and Drug Administration (FDA) […]

Continue Reading

Editorial Message and Issue Highlights–Vol. 15, No. 3–4, March-April 2018

Editorial Message and Issue Highlights–Vol. 15, No. 3–4, March-April 2018

| April 1, 2018 | 0 Comments

Continue Reading